Tenofovir (25mg)
Tenvir-AF Tablet is prescribed for the treatment of chronic hepatitis B virus (HBV) infection and HIV infection. The medication functions by preventing the replication of the virus within human cells, thereby preventing the production of new viruses and aiding in the resolution of the infection.
Headache, diarrhea, vertigo, joint pain, abdominal pain, indigestion, lethargy, and cough are among the commonly reported adverse effects of Tenvir-AF Tablet. These adverse effects are generally moderate and frequently subside as your body acclimates to the medication. Nevertheless, it is advisable to seek the advice of a physician if the symptoms persist or aggravate. In uncommon instances, some individuals may experience more severe reactions, such as liver damage or skin rashes, especially during the initial phases of treatment.
1 Bottle of 30 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Tenvir-AF Tablet should be administered in accordance with the doctor's instructions regarding dosage and duration. Be certain to finish the entire course of treatment, even if you begin to feel better, and do not neglect any dosages. Take the tablet with food to improve absorption, and continue to take the medication until your physician instructs you otherwise.
Tenvir-AF Tablet is an antiviral medication that prevents the virus from replicating in human cells. This inhibits the production of new viruses and aids in the removal of the infection from the body.
Related Warnings
The interaction between alcohol and Tenvir-AF Tablet is not well-established. It is recommended that you consult with your physician about the consumption of alcohol while taking this medication.
Tenvir-AF Tablet is generally regarded as secure for use during pregnancy. Animal studies have demonstrated minimal or no adverse effects on the developing fetus; however, there is a scarcity of human data. It is recommended that pregnant women consult with their healthcare provider prior to taking this medication.
It is probable that Tenvir-AF Tablet is harmless for use during lactation. The drug does not appear to pose a substantial risk to the suckling neonate, according to the limited human data available. Conversely, seek guidance from your physician regarding your individual circumstances.
The potential side effects of Tenvir-AF Tablet include vertigo, drowsiness, or impaired vision, which could potentially impede your ability to operate machinery or drive. Refrain from engaging in such activities until you have a clear understanding of the medication's impact on you.
In patients with kidney disease, Tenvir-AF Tablet should be administered with caution. It is imperative to adhere to your physician's recommendations, as dosage adjustments may be required.
Tenvir-AF Tablet is generally harmless for patients with hepatic disease. Nevertheless, the availability of limited data indicates that dosage adjustments may not be necessary. Your physician should be consulted for personalized advice.
Q: Does Tenvir-AF Tablet prevent the transmission of HIV-1 and HBV to others?
A: Tenvir-AF Tablet may mitigate the risk of HIV-1 transmission; however, it does not eradicate it. There is no evidence to imply that HBV prevents transmission. It is advised to adhere to safe sex practices and refrain from sharing personal items or syringes.
Q: Is Tenvir-AF Tablet a safe product?
A: Tenvir-AF Tablet is safe when used in accordance with the instructions provided by your physician. It is crucial to disclose any bothersome side effects and adhere strictly to your doctor's instructions.
Q: What is the recommended method of administration for Tenvir-AF Tablet?
A: It is recommended that you consume Tenvir-AF Tablet in accordance with the physician's instructions, preferably with food to optimize absorption. Complete the entire course of treatment and ensure that no medications are missed.
Q: What is the recommended duration of treatment for HBV infection with Tenvir-AF Tablet?
A: The duration of treatment is contingent upon the severity of the infection. Periodic blood tests will be conducted by your physician to monitor your viral load and T-cell count, and the duration of your treatment will be determined accordingly. Lifelong treatment may be required in certain instances.
Q: What should I do if I vomit after consuming Tenvir-AF Tablet?
A: If vomiting occurs within one hour of ingesting Tenvir-AF Tablet, administer an additional dose. An additional dose is not necessary if vomiting occurs after a period of more than one hour. If vomiting continues, it is recommended that you consult with your physician.
Q: What should I do if I neglect to take Tenvir-AF Tablet?
A: If you forget to take a dose and remember within 12 hours, take the tablet with sustenance as soon as possible and remain on your regular schedule. Skip the delayed dose and resume your regular dosing schedule if it has been more than 12 hours. Avoid administering multiple doses.
